Bristol Myers Squibb

In oncology, hematology, immunology, neuroscience, and cardiovascular disease – and one of the most diverse and promising pipelines in the industry – each of our passionate colleagues contribute to innovations that drive meaningful change.. As part of the Discovery Biotherapeutics efforts at BMS, the Principal Scientist will play a key role in advancing antibody drug conjugates technologies at BMS. We are looking for an experienced, collaborative, highly motivated scientist and leader with deep expertise in antibody drug conjugates (ADC) technologies.. The candidate is expected to have strong collaborative skills to ensure robust partnerships with biologists, antibody discovery and engineering & bioanalytical scientists to advance ADC projects.. Responsibilities:The role will involve leading and carrying out laboratory experiments related to ADC conjugation, associated purification and analytical characterization of the conjugatesDesign, produce, and characterize antibody-drug conjugates (ADCs) with a high degree of independenceProactively advise and share knowledge and expert opinions with bench scientists, peers and senior management.. Experience in development of purification strategies using various chromatographic techniques such as affinity, size exclusion, ion-exchange, hydrophobic interaction, and tangential flow filtration (TFF)Experience in analytical characterization of ADCs including SEC, RP-HPLC, LC-MS, CE-SDS, ELISA, DSC, and HICExperience with biological assays such as measuring cytotoxic activity for ADC characterization.

principal scientist

Working with UsChallenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams rich in diversity. Take your career farther than you thought possible.At Bristol Myers Squibb, we are inspired by a single vision – transforming patients’ lives through science. In oncology, hematology, immunology, neuroscience, and cardiovascular disease – and one of the most diverse and promising pipelines in the industry – each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.As part of the Discovery Biotherapeutics efforts at BMS, the Principal Scientist will play a key role in advancing antibody drug conjugates technologies at BMS. We are looking for an experienced, collaborative, highly motivated scientist and leader with deep expertise in antibody drug conjugates (ADC) technologies. The candidate should have deep understanding and experience antibody drug conjugation technologies. The candidate is expected to have strong collaborative skills to ensure robust partnerships with biologists, antibody discovery and engineering & bioanalytical scientists to advance ADC projects.A prove track record of hands-on experience with antibody-drug conjugation chemistry, analytical characterization and developability of ADCs is a must have for this position.Responsibilities:The role will involve leading and carrying out laboratory experiments related to ADC conjugation, associated purification and analytical characterization of the conjugatesDesign, produce, and characterize antibody-drug conjugates (ADCs) with a high degree of independenceProactively advise and share knowledge and expert opinions with bench scientists, peers and senior management. Mentor staff in troubleshooting strategic and experimental issuesRecord of leading project teams through different stages of pre-clinical discoveryEnsure highest standard of quality in antibody-conjugate productions in alignment with product development guidelines and QC criteriaCollaborate with a diverse team of biologists and chemists to answer scientific questions and drive forward new conjugation platformsLeverage knowledge of bioconjugation and protein engineering to develop new therapeutic ADC technologies.The candidate will encourage ideas for continuous improvement activities & new technology development and initiative within work group.Contribute to patents, publications, and technical reports.Basic Qualifications:Bachelor’s Degree with 8+ years of academic or industry experienceOrMaster’s Degree with 6+ years of academic or industry experienceOrPhD with 4+ years of academic or industry experiencePreferred Qualifications:A PhD with 4+ years of industry experienceExtensive hands-on experience with therapeutic antibody and ADC discoveryDeep knowledge of bioconjugation chemistries (lysine, inter-chain cysteine and/or site-specific cysteine and other) is needed.Experience in development of purification strategies using various chromatographic techniques such as affinity, size exclusion, ion-exchange, hydrophobic interaction, and tangential flow filtration (TFF)Experience in analytical characterization of ADCs including SEC, RP-HPLC, LC-MS, CE-SDS, ELISA, DSC, and HICExperience with biological assays such as measuring cytotoxic activity for ADC characterization.Hands-on experience with siRNA/ASO conjugations and analytics is a plus.Demonstrated record of scientific accomplishments and publications.Excellent written and oral communication skills and ability to interpret results and contribute to multidisciplinary biologics discovery teamsUniquely Interesting Work, Life-changing CareersWith a single vision as inspiring as “Transforming patients’ lives through science™ ”, every BMS employee plays an integral role in work that goes far beyond ordinary. Each of us is empowered to apply our individual talents and unique perspectives in an inclusive culture, promoting diversity in clinical trials, while our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.On-site ProtocolBMS has a diverse occupancy structure that determines where an employee is required to conduct their work. This structure includes site-essential, site-by-design, field-based and remote-by-design jobs. The occupancy type that you are assigned is determined by the nature and responsibilities of your role:Site-essential roles require 100% of shifts onsite at your assigned facility. Site-by-design roles may be eligible for a hybrid work model with at least 50% onsite at your assigned facility. For these roles, onsite presence is considered an essential job function and is critical to collaboration, innovation, productivity, and a positive Company culture. For field-based and remote-by-design roles the ability to physically travel to visit customers, patients or business partners and to attend meetings on behalf of BMS as directed is an essential job function.BMS is dedicated to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace accommodations/adjustments and ongoing support in their roles. Applicants can request a reasonable workplace accommodation/adjustment prior to accepting a job offer. If you require reasonable accommodations/adjustments in completing this application, or in any part of the recruitment process, direct your inquiries to . Visit to access our complete Equal Employment Opportunity statement.BMS cares about your well-being and the well-being of our staff, customers, patients, and communities. As a result, the Company strongly recommends that all employees be fully vaccinated for Covid-19 and keep up to date with Covid-19 boosters.BMS will consider for employment qualified applicants with arrest and conviction records, pursuant to applicable laws in your area.Any data processed in connection with role applications will be treated in accordance with applicable data privacy policies and regulations.

START NEW SEARCH